Overview
Fara Maristany-Braso practices in Barcelona, Spain. Ms. Maristany-Braso is rated as an Elite expert by MediFind in the treatment of Breast Cancer. Her top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, Mastectomy, and Salpingo-Oophorectomy.
Her clinical research consists of co-authoring 86 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 77 articles in the study of Breast Cancer.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Breast CancerMs. Maristany-Braso isElite. Learn about Breast Cancer.
- HER-2 Positive Breast CancerMs. Maristany-Braso isElite. Learn about HER-2 Positive Breast Cancer.
- Distinguished
- Triple-Negative Breast CancerMs. Maristany-Braso isDistinguished. Learn about Triple-Negative Breast Cancer.
- Experienced
- Bone TumorMs. Maristany-Braso isExperienced. Learn about Bone Tumor.
- Inflammatory Breast CancerMs. Maristany-Braso isExperienced. Learn about Inflammatory Breast Cancer.
- Lung MetastasesMs. Maristany-Braso isExperienced. Learn about Lung Metastases.
- LymphangitisMs. Maristany-Braso isExperienced. Learn about Lymphangitis.
- MastectomyMs. Maristany-Braso isExperienced. Learn about Mastectomy.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)Ms. Maristany-Braso isExperienced. Learn about Monoclonal Gammopathy of Undetermined Significance (MGUS).